Basilea Pharmaceutica AG (LON: 0QNA)

Basilea Pharmaceutica AG Revenue

Basilea Pharmaceutica AG had revenue of 76.29M CHF in the half year ending June 30, 2024, with 32.35% growth. This brings the company's revenue in the last twelve months to 149.02M, down -14.86% year-over-year. In the year 2023, Basilea Pharmaceutica AG had annual revenue of 157.63M with 6.68% growth.

• Revenue (ttm): 149.02M CHF
• Revenue Growth: -14.86%
• P/S Ratio: n/a
• Revenue / Employee: 1.01M CHF
• Employees: 147
• Market Cap: 428.91M GBP

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	157.63M	9.87M	6.68%
Dec 31, 2022	147.77M	-357.00K	-0.24%
Dec 31, 2021	148.12M	20.49M	16.06%
Dec 31, 2020	127.63M	-6.75M	-5.02%
Dec 31, 2019	134.38M	1.83M	1.38%